Content (Accesskey 0)
Navigation (Accesskey 1)
About us
Events
How to contact us
What's new
Accessibility
Legal notice
Privacy notice
close
search
search
search
Deutsch
English
menu
Market Surveillance
Official announcements
Messages in brief
Human medicines
Veterinary medicines
Blood & tissue
Medical devices
Illegal market
Public registers
Certified SARS-CoV-2 antigen rapid tests
Medicine shortages catalogue
open_in_new
Catalogue according to the regulation on ensuring the provision of medicinal products
open_in_new
Austrian Medicinal Product Index
open_in_new
Pharmaceutical companies
Register of retailers
Internet pharmacies
open_in_new
Non-interventional studies
open_in_new
BASG official announcement
open_in_new
BASG voting results
open_in_new
Reporting
Human adverse reaction notification
Veterinary Adverse Event Reports
Quality defects
Medicine shortages
Illegal occurrences
Medical devices vigilance
Haemovigilance
Tissue vigilance
MedSafety Week 2020
For Consumers
Facts worth knowing about medicines
Medicinal products
Vaccines
Administration of medicines
Package leaflet
Prescription/Non-prescription requirements
Ability to drive
Medication allergies
Doping
Expiry date and storage of medicines
Disposal of medicinal products
Useful Links
Clinical Trials
Clinical studies and the war in Ukraine
EUPATI
Austrian information center regarding clinical trials for cancer therapy
Medicines from the Internet
Online medicine retailers
Illegal websites
Illegal market
Enforcement
Falsified medicines
"Predatory publishers" and their effect
Glossary
Medical devices
For Healthcare Professionals
Safety information (DHPC)
Clinical trials
Clinical trials and the war in Ukraine
Clinical studies and COVID-19
Clinial trials with medicinal products
Good Clinical Practice
Non-Interventional-Studies NIS
Compassionate use/Named Patient Use
Clinical investigations with medical devices
Blood safety
Authorisation and inspection of blood establishments
Tissue safety
Certification, authorisation, and inspection of tissue establishments
Medical Device Operators
FAQ's medical device operators
Bringing into circulation
Supply of drugs for COVID-19 therapy
Dispensing of veterinary antibiotics
Internet pharmacy
Self-assessment of pharmacies
Sampling
Austrian Pharmacopoeia
Draft monographs for comments
Archive of monographs
Archive of deleted monographs
CHMP Meeting Highlights-BASG
The CHMP introduces itself
For Companies
Online services
Login online services
open_in_new
Login Vigiweb
open_in_new
Reporting adverse reactions
open_in_new
Login NIS
open_in_new
Registration online services
open_in_new
Contact
Veterinary Antimicrobial Consumption
Data provision medicine shortages
Data provision Falsified Medicines Directive
FAQ online Service
PHAROS user group
Instructions for use
Marketing authorisation & life-cycle
Marketing authorisation procedure
Austria as RMS
Electronic application
AGES eValidator
FAQ electronic Submission
Life-Cycle
Commission decisions
Forms for medicinal products
Change of ownership acc. to Art 25 AMG
Veterinary medicinal products
FAQ marketing authorisation & life-cycle
Pharmacovigilance
Pharmacovigilance inspection
PHV-wordings
Submission of Periodic Safety Update Reports (PSURs)
FAQ pharmacovigilance
Guideline pharmacovigilance
Medicinal products
Scientific advice by BASG
Quality of medicines
Medicines for children
Plasma derived products
Batch release
Recombinant proteins
Addictive drugs
Radiopharmaceuticals
Import and export of medicines
Import of medicines
FAQ Import of medicinal products
Certificate for a Pharmaceutical Product (CPP)
Medical devices
COVID 19
Manufacturer
Importer
Medical devices fee
Free Sale Certificate - (FSC)
MDR / IVDR
Authorisation and certification
GMP/ GDP
Good Laboratory Practice (GLP)
IT inspections
Borderline products
Decisions of the AGBR
Home
About us
BASG publications
BASG approval procedure
BASG Protocols
BASG Protocols
060524_Veroeffentlichungsprotokoll.pdf
| 58 KB
11/01/2021
060602_Veroeffentlichungsprotokoll.pdf
| 100 KB
11/01/2021
060609_Veroeffentlichungsprotokoll.pdf
| 46 KB
11/01/2021
060614_Veroeffentlichungsprotokoll.pdf
| 54 KB
11/01/2021
060623_Veroeffentlichungsprotokoll.pdf
| 84 KB
11/01/2021
060623_Veroeffentlichungsprotokoll_Zusatz.pdf
| 32 KB
11/01/2021
060630_Veroeffentlichungsprotokoll.PDF
| 160 KB
11/01/2021
060707_Veroeffentlichungsprotokoll.PDF
| 151 KB
11/01/2021
060714_Veroeffentlichungsprotokoll.PDF
| 172 KB
11/01/2021
060721_Veroeffentlichungsprotokoll.PDF
| 201 KB
11/01/2021
060728_Veroeffentlichungsprotokoll.pdf
| 174 KB
11/01/2021
060804_Veroeffentlichungsprotokoll.PDF
| 215 KB
11/01/2021
060811_Veroeffentlichungsprotokoll.PDF
| 168 KB
11/01/2021
060818_Veroeffentlichungsprotokoll.PDF
| 159 KB
11/01/2021
060825_Veroeffentlichungsprotokoll.PDF
| 131 KB
11/01/2021
060901_Veroeffentlichungsprotokoll.PDF
| 165 KB
11/01/2021
060908_Veroeffentlichungsprotokoll.PDF
| 198 KB
11/01/2021
060915_Veroeffentlichungsprotokoll.PDF
| 160 KB
11/01/2021
060922_Veroeffentlichungsprotokoll.PDF
| 175 KB
11/01/2021
060929_Veroeffentlichungsprotokoll.PDF
| 199 KB
11/01/2021
Previous
1
2
(current)
3
4
5
6
7
....
17
Next
Further inquiry note
basg@basg.gv.at
Page last modified: 27/08/2014
Navigation
close
Market Surveillance
»
Zurück
Market Surveillance
Official announcements
»
Zurück
Official announcements
Messages in brief
Human medicines
Veterinary medicines
Blood & tissue
Medical devices
Illegal market
Public registers
»
Zurück
Public registers
Certified SARS-CoV-2 antigen rapid tests
Medicine shortages catalogue
open_in_new
Catalogue according to the regulation on ensuring the provision of medicinal products
open_in_new
Austrian Medicinal Product Index
open_in_new
Pharmaceutical companies
Register of retailers
Internet pharmacies
open_in_new
Non-interventional studies
open_in_new
BASG official announcement
open_in_new
BASG voting results
open_in_new
Reporting
»
Zurück
Reporting
Human adverse reaction notification
Veterinary Adverse Event Reports
»
Zurück
Veterinary Adverse Event Reports
FAQ adverse events veterinary
Quality defects
Medicine shortages
Illegal occurrences
Medical devices vigilance
Haemovigilance
Tissue vigilance
MedSafety Week 2020
For Consumers
»
Zurück
For Consumers
Facts worth knowing about medicines
»
Zurück
Facts worth knowing about medicines
Medicinal products
»
Zurück
Medicinal products
Classification guide for cell and tissue products
Generics and Biosimilars
Herbal medicinal products
Veterinary medicinal products
Vaccines
»
Zurück
Vaccines
FAQ Vaccines
Administration of medicines
Package leaflet
»
Zurück
Package leaflet
Black triangle
Visually impaired patients
Off Label Use
Prescription/Non-prescription requirements
Ability to drive
Medication allergies
Doping
Expiry date and storage of medicines
Disposal of medicinal products
Useful Links
Clinical Trials
»
Zurück
Clinical Trials
Clinical studies and the war in Ukraine
EUPATI
Austrian information center regarding clinical trials for cancer therapy
Medicines from the Internet
»
Zurück
Medicines from the Internet
Online medicine retailers
»
Zurück
Online medicine retailers
FAQs - internet pharmacies
Illegal websites
Illegal market
»
Zurück
Illegal market
Enforcement
Falsified medicines
"Predatory publishers" and their effect
Glossary
Medical devices
For Healthcare Professionals
»
Zurück
For Healthcare Professionals
Safety information (DHPC)
Clinical trials
»
Zurück
Clinical trials
Clinical trials and the war in Ukraine
Clinical studies and COVID-19
»
Zurück
Clinical studies and COVID-19
FAQ - COVID-19 studies
Clinial trials with medicinal products
»
Zurück
Clinial trials with medicinal products
Recommendations for preparation for Reg (EU) 536/2014
Pharmacovigilance for Clinical Trials with Medicinal Products
EU Clinical Trials Register
Good Clinical Practice
»
Zurück
Good Clinical Practice
FAQ - Documentation (GCP)
FAQ - Regulatory Requirements (GCP)
FAQ - Import of Investigational Medicinal Products
FAQ - Identification of Investigational Medicinal Products
FAQ - Handling of Investigational Medicinal Products
FAQ - Addictive substances as investigational drugs
Non-Interventional-Studies NIS
»
Zurück
Non-Interventional-Studies NIS
FAQ
Compassionate use/Named Patient Use
Clinical investigations with medical devices
»
Zurück
Clinical investigations with medical devices
Procedures for Clinical Trials after the Brexit
Blood safety
»
Zurück
Blood safety
Authorisation and inspection of blood establishments
Tissue safety
»
Zurück
Tissue safety
Certification, authorisation, and inspection of tissue establishments
Medical Device Operators
»
Zurück
Medical Device Operators
FAQ's medical device operators
Bringing into circulation
»
Zurück
Bringing into circulation
Supply of drugs for COVID-19 therapy
Dispensing of veterinary antibiotics
Internet pharmacy
Self-assessment of pharmacies
Sampling
Austrian Pharmacopoeia
»
Zurück
Austrian Pharmacopoeia
Draft monographs for comments
Archive of monographs
Archive of deleted monographs
CHMP Meeting Highlights-BASG
»
Zurück
CHMP Meeting Highlights-BASG
The CHMP introduces itself
For Companies
»
Zurück
For Companies
Online services
»
Zurück
Online services
Login online services
open_in_new
Login Vigiweb
open_in_new
Reporting adverse reactions
open_in_new
Login NIS
open_in_new
Registration online services
open_in_new
Contact
Veterinary Antimicrobial Consumption
»
Zurück
Veterinary Antimicrobial Consumption
Provision of data
Extension DDDVet, DCDVet
FAQ antibiotics flow
Data provision medicine shortages
Data provision Falsified Medicines Directive
FAQ online Service
»
Zurück
FAQ online Service
FAQ Registration
FAQ User rights
FAQ online services
FAQ Notification medicine shortages
PHAROS user group
Instructions for use
»
Zurück
Instructions for use
System requirements for electronic submission
Marketing authorisation & life-cycle
»
Zurück
Marketing authorisation & life-cycle
Marketing authorisation procedure
»
Zurück
Marketing authorisation procedure
Central Authorisation
MRP/DCP authorisation
»
Zurück
MRP/DCP authorisation
Conditional Authorisation
Letter of Authorisation
MRP/DCP - national translations
Withdrawal during the authorisation procedure
National Authorisation
Line Extension
Utilisation of genetic resources and traditional knowledge associated with genetic resources
Parallel import
Accessible patient information leaflet
Safety features AMVS
Classification and supply of substances under control
»
Zurück
Classification and supply of substances under control
Prescription of medicines
Austria as RMS
»
Zurück
Austria as RMS
DCP/MRP/RUP Slots
RMS transfer
RMS NEWS
Electronic application
AGES eValidator
FAQ electronic Submission
Life-Cycle
Commission decisions
Forms for medicinal products
»
Zurück
Forms for medicinal products
National authorisation Life-Cycle forms
Change of ownership acc. to Art 25 AMG
Veterinary medicinal products
»
Zurück
Veterinary medicinal products
Austria as RMS
open_in_new
The new EU veterinary medicinal products regulation
»
Zurück
The new EU veterinary medicinal products regulation
European guidelines
Implementation status in Austria
Application for Marketing Authorisation and Variations
Implementation of new QRD templates
SPC harmonisation of veterinary medicinal products
Clinical trials
Pharmacovigilance
Union Product Database (UPD)
»
Zurück
Union Product Database (UPD)
Nomenclature of the texts
Organization Management Service (OMS)
Antimicrobial Consumption
open_in_new
Contact
FAQ marketing authorisation & life-cycle
»
Zurück
FAQ marketing authorisation & life-cycle
Application for variation
»
Zurück
Application for variation
Variations to MRP and DCP authorisations
Variations to national authorisations
Approval Letter following Variation
End of Procedure date in case of Type IA/IAin Variations
Austrian Medicinal Product Index
ASMF
Decisions - electronic delivery
Braille writing system
Batch release
Anti-doping warning
Elemental Impurities - ICHQ3D
Environmental Risk Assessment - ERA
SmPC and PL
Accessible patient information leaflet
Homeopathic Medicinal Products
Annual fee
Medicines for children/Paediatric Worksharing
Mock-ups
Naming of medicinal products
Parallelimport
Herbal Medicinal Products
Black Triangle
Sunset clause
Renewal of marketing authorisation
Distributor in Austria
Authorisation/registration applications
Pharmacovigilance
»
Zurück
Pharmacovigilance
Pharmacovigilance inspection
PHV-wordings
Submission of Periodic Safety Update Reports (PSURs)
FAQ pharmacovigilance
Guideline pharmacovigilance
Medicinal products
»
Zurück
Medicinal products
Scientific advice by BASG
Quality of medicines
Medicines for children
Plasma derived products
Batch release
Recombinant proteins
Addictive drugs
»
Zurück
Addictive drugs
Forms
FAQ Suchtmittel
Radiopharmaceuticals
Import and export of medicines
»
Zurück
Import and export of medicines
Import of medicines
FAQ Import of medicinal products
Certificate for a Pharmaceutical Product (CPP)
Medical devices
»
Zurück
Medical devices
COVID 19
Manufacturer
Importer
Medical devices fee
Free Sale Certificate - (FSC)
MDR / IVDR
Authorisation and certification
»
Zurück
Authorisation and certification
GMP/ GDP
»
Zurück
GMP/ GDP
FAQ - GMP/GDP
FAQ - reportable qualified persons
FAQ - human plasma for fractionation
FAQ - enforcement
Good Laboratory Practice (GLP)
»
Zurück
Good Laboratory Practice (GLP)
FAQ - GLP
IT inspections
»
Zurück
IT inspections
FAQ - CAS
Borderline products
»
Zurück
Borderline products
Decisions of the AGBR
About us
»
Zurück
About us
Vision, values and strategy
Activities
Legal basis
»
Zurück
Legal basis
Legal ordinances of BASG
BASG publications
»
Zurück
BASG publications
BASG approval procedure
»
Zurück
BASG approval procedure
BASG Protocols
BASG announcements
Rules of Procedure (in German only)
Fees
»
Zurück
Fees
Official announcements
Quality Management
European Network
Scientific Board
Statistics
»
Zurück
Statistics
Reports COVID-19 Vaccination
Statistics on reporting
Publications
»
Zurück
Publications
Annual Reports
Folder
Scientific Publications
Official electronic signature
Press
»
Zurück
Press
Photos
Events
open_in_new
How to contact us
What's new
»
Zurück
What's new
Registration and cancellation
RSS
Accessibility
»
Zurück
Accessibility
Accessibility of the online form for reporting of suspected adverse reactions (vaccines/medicines)
Legal notice
Privacy notice